Table 3. Molecular subtype of newly diagnosed breast cancer in 2017 in Korea (KBCS registry data).
| Molecular subtype | No. of patients |
|---|---|
| HR (+), HER2 (−) | 6,377 (65.9) |
| HR (+), HER2 (+) | 1,133 (11.7) |
| HR (−), HER2 (+) | 981 (10.2) |
| HR (−), HER2 (−) | 1,183 (12.2) |
| Total | 9,674 (100.0) |
Values are presented as number (%).
KBCS = Korean Breast Cancer Society; HR = hormone receptor; HER2 = human epidermal growth factor receptor-2.